Kearney, P.M. et al. Global burden of hypertension: analysis of worldwide data. Lancet 365, 217–223 (2005).
Levey, A.S. et al. Chronic kidney disease as a global public health problem: approaches and initiatives–a position statement from Kidney Disease Improving Global Outcomes. Kidney Int. 72, 247–259 (2007).
Padmanabhan, S. et al. Genome-wide association study of blood pressure extremes identifies variant near UMOD associated with hypertension. PLoS Genet. 6, e1001177 (2010).
Köttgen, A. et al. Multiple loci associated with indices of renal function and chronic kidney disease. Nat. Genet. 41, 712–717 (2009).
Köttgen, A. et al. New loci associated with kidney function and chronic kidney disease. Nat. Genet. 42, 376–384 (2010).
Pattaro, C. et al. A meta-analysis of genome-wide data from five European isolates reveals an association of COL22A1, SYT1, and GABRR2 with serum creatinine level. BMC Med. Genet. 11, 41 (2010).
Gudbjartsson, D.F. et al. Association of variants at UMOD with chronic kidney disease and kidney stones-role of age and comorbid diseases. PLoS Genet. 6, e1001039 (2010).
Böger, C.A. et al. Association of eGFR-related loci identified by GWAS with incident CKD and ESRD. PLoS Genet. 7, e1002292 (2011).
Pattaro, C. et al. Genome-wide association and functional follow-up reveals new loci for kidney function. PLoS Genet. 8, e1002584 (2012).
Lifton, R.P., Gharavi, A.G. & Geller, D.S. Molecular mechanisms of human hypertension. Cell 104, 545–556 (2001).
Boyden, L.M. et al. Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities. Nature 482, 98–102 (2012).
Eckardt, K.U. et al. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet 382, 158–169 (2013).
O'Seaghdha, C.M. & Fox, C.S. Genome-wide association studies of chronic kidney disease: what have we learned? Nat. Rev. Nephrol. 8, 89–99 (2012).
Padmanabhan, S., Newton-Cheh, C. & Dominiczak, A.F. Genetic basis of blood pressure and hypertension. Trends Genet. 28, 397–408 (2012).
Rampoldi, L., Scolari, F., Amoroso, A., Ghiggeri, G. & Devuyst, O. The rediscovery of uromodulin (Tamm-Horsfall protein): from tubulointerstitial nephropathy to chronic kidney disease. Kidney Int. 80, 338–347 (2011).
Bates, J.M. et al. Tamm-Horsfall protein knockout mice are more prone to urinary tract infection: rapid communication. Kidney Int. 65, 791–797 (2004).
Liu, Y. et al. Progressive renal papillary calcification and ureteral stone formation in mice deficient for Tamm-Horsfall protein. Am. J. Physiol. Renal Physiol. 299, F469–F478 (2010).
Bachmann, S. et al. Renal effects of Tamm-Horsfall protein (uromodulin) deficiency in mice. Am. J. Physiol. Renal Physiol. 288, F559–F567 (2005).
Mutig, K. et al. Activation of the bumetanide-sensitive Na+,K+,2Cl− cotransporter (NKCC2) is facilitated by Tamm-Horsfall protein in a chloride-sensitive manner. J. Biol. Chem. 286, 30200–30210 (2011).
Renigunta, A. et al. Tamm-Horsfall glycoprotein interacts with renal outer medullary potassium channel ROMK2 and regulates its function. J. Biol. Chem. 286, 2224–2235 (2011).
Hart, T.C. et al. Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy. J. Med. Genet. 39, 882–892 (2002).
Eddy, A.A. Scraping fibrosis: UMODulating renal fibrosis. Nat. Med. 17, 553–555 (2011).
Bernascone, I. et al. A transgenic mouse model for uromodulin-associated kidney diseases shows specific tubulo-interstitial damage, urinary concentrating defect and renal failure. Hum. Mol. Genet. 19, 2998–3010 (2010).
Simpson, R.U., Hershey, S.H. & Nibbelink, K.A. Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse. J. Steroid Biochem. Mol. Biol. 103, 521–524 (2007).
Han, J. et al. Age-related changes in blood pressure in the senescence-accelerated mouse (SAM): aged SAMP1 mice manifest hypertensive vascular disease. Lab. Anim. Sci. 48, 256–263 (1998).
Schreiber, A. et al. Transcutaneous measurement of renal function in conscious mice. Am. J. Physiol. Renal Physiol. 303, F783–F788 (2012).
Giménez, I. & Forbush, B. Regulatory phosphorylation sites in the NH2 terminus of the renal Na-K-Cl cotransporter (NKCC2). Am. J. Physiol. Renal Physiol. 289, F1341–F1345 (2005).
Ponce-Coria, J. et al. Regulation of NKCC2 by a chloride-sensing mechanism involving the WNK3 and SPAK kinases. Proc. Natl. Acad. Sci. USA 105, 8458–8463 (2008).
Schaeffer, C., Santambrogio, S., Perucca, S., Casari, G. & Rampoldi, L. Analysis of uromodulin polymerization provides new insights into the mechanisms regulating ZP domain-mediated protein assembly. Mol. Biol. Cell 20, 589–599 (2009).
Piechotta, K., Lu, J. & Delpire, E. Cation chloride cotransporters interact with the stress-related kinases Ste20-related proline-alanine-rich kinase (SPAK) and oxidative stress response 1 (OSR1). J. Biol. Chem. 277, 50812–50819 (2002).
Richardson, C. et al. Regulation of the NKCC2 ion cotransporter by SPAK-OSR1-dependent and -independent pathways. J. Cell Sci. 124, 789–800 (2011).
McCormick, J.A. et al. A SPAK isoform switch modulates renal salt transport and blood pressure. Cell Metab. 14, 352–364 (2011).
Devuyst, O. Salt wasting and blood pressure. Nat. Genet. 40, 495–496 (2008).
Ying, W.Z. & Sanders, P.W. Dietary salt regulates expression of Tamm-Horsfall glycoprotein in rats. Kidney Int. 54, 1150–1156 (1998).
Torffvit, O., Melander, O. & Hulten, U.L. Urinary excretion rate of Tamm-Horsfall protein is related to salt intake in humans. Nephron Physiol. 97, 31–36 (2004).
Stubbe, J., Madsen, K., Nielsen, F.T., Skott, O. & Jensen, B.L. Glucocorticoid impairs growth of kidney outer medulla and accelerates loop of Henle differentiation and urinary concentrating capacity in rat kidney development. Am. J. Physiol. Renal Physiol. 291, F812–F822 (2006).
Ferrandi, M. et al. α- and β-adducin polymorphisms affect podocyte proteins and proteinuria in rodents and decline of renal function in human IgA nephropathy. J. Mol. Med. 88, 203–217 (2010).
Mulder, W.J. & Hillen, H.F. Renal function and renal disease in the elderly: Part I. Eur. J. Intern. Med. 12, 86–97 (2001).
Chen, G. et al. Increased susceptibility of aging kidney to ischemic injury: identification of candidate genes changed during aging, but corrected by caloric restriction. Am. J. Physiol. Renal Physiol. 293, F1272–F1281 (2007).
Genovese, G. et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329, 841–845 (2010).
Manunta, P. et al. Physiological interaction between α-adducin and WNK1-NEDD4L pathways on sodium-related blood pressure regulation. Hypertension 52, 366–372 (2008).
Pruijm, M. et al. Heritability, determinants and reference values of renal length: a family-based population study. Eur. Radiol. 23, 2899–2905 (2013).
National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am. J. Kidney Dis. 39, S1–S266 (2002).
Youhanna, S. et al. Determination of uromodulin in human urine: influence of storage and processing. Nephrol. Dial. Transplant. 10.1093/ndt/gft345 (3 October 2013).
Dahan, K. et al. A cluster of mutations in the UMOD gene causes familial juvenile hyperuricemic nephropathy with abnormal expression of uromodulin. J. Am. Soc. Nephrol. 14, 2883–2893 (2003).
Barr, D.B. et al. Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ. Health Perspect. 113, 192–200 (2005).
Bourgeois, S. et al. Differentiated thick ascending limb (TAL) cultured cells derived from SV40 transgenic mice express functional apical NHE2 isoform: effect of nitric oxide. Pflugers Arch. 446, 672–683 (2003).
Terryn, S. A primary culture of mouse proximal tubular cells, established on collagen-coated membranes. Am. J. Physiol. Renal Physiol. 293, F476–F485 (2007).
Glaudemans, B. et al. A primary culture system of mouse thick ascending limb cells with preserved function and uromodulin processing. Pflugers Arch. 10.1007/s00424-013-1321-1 (26 July 2013).
Zaarour, N., Demaretz, S., Defontaine, N., Mordasini, D. & Laghmani, K. A highly conserved motif at the COOH terminus dictates endoplasmic reticulum exit and cell surface expression of NKCC2. J. Biol. Chem. 284, 21752–21764 (2009).
Rozen, S. & Skaletsky, H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol. Biol. 132, 365–386 (2000).
Pfaffl, M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45 (2001).
Hummon, A.B., Lim, S.R., Difilippantonio, M.J. & Ried, T. Isolation and solubilization of proteins after TRIzol extraction of RNA and DNA from patient material following prolonged storage. Biotechniques 42, 467–470, 472 (2007).
Sorensen, M.V. et al. Rapid dephosphorylation of the renal sodium chloride cotransporter in response to oral potassium intake in mice. Kidney Int. 83, 811–824 (2013).
Flemmer, A.W., Gimenez, I., Dowd, B.F.X., Darman, R.B. & Forbush, B. Activation of the Na-K-Cl cotransporter NKCC1 detected with a phospho-specific antibody. J. Biol. Chem. 277, 37551–37558 (2002).
Rafiqi, F.H. et al. Role of the WNK-activated SPAK kinase in regulating blood pressure. EMBO Mol. Med. 2, 63–75 (2010).
Wagner, C.A. et al. Mouse model of type II Bartter's syndrome. II. Altered expression of renal sodium- and water-transporting proteins. Am. J. Physiol. Renal Physiol. 294, F1373–F1380 (2008).
Waterhouse, A.M., Procter, J.B., Martin, D.M., Clamp, M. & Barton, G.J. Jalview Version 2–a multiple sequence alignment editor and analysis workbench. Bioinformatics 25, 1189–1191 (2009).